Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04342546 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction

Study acronym: PRETORIA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 2026 to Dec 10, 2029
    • Study completion date: Jun 2027 to Dec 10, 2031
    v9
  2. Re-verified, no change to tracked fieldsv8
  3. Study sites: 8 to 9
    • Eligibility criteria shortened, about 10 words
    v7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary completion date: May 2024 to Jun 2026v5 Show 4 more changesShow less
    • Study completion date: May 2025 to Jun 2027
    • Start date: Nov 23, 2020 to Dec 11, 2020
    • Eligibility criteria expanded, about 6 words
    • Site details revised at 1 of 8 sites
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 6 to 8v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2020 to Nov 23, 2020
    • Site details revised at 6 of 6 sites
    v3
  3. Start date: Jun 2020 to Dec 2020v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluates the capacity of the NovaGray RILA Breast® test to predict the toxicity linked to radiotherapy and the impact of implant breast reconstruction.
Trial Details
NCT Number NCT04342546
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions
(from sponsor)		 Breast Cancer, Capsular Contracture Associated With Breast Implant
Related terms Breast Neoplasms
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov